Basic Information
LncRNA/CircRNA Name | MIR4697HG |
Synonyms | MIR4697HG, LINC00947 |
Region | GRCh38_11:133896438-133901601 |
Ensemble | ENSG00000280237 |
Refseq | NR_024344 |
Classification Information
Regulatory Mechanism | Biological Function | Clinical Application | |||
---|---|---|---|---|---|
TF | Immune | Survival | |||
Enhancer | Apoptosis | apoptosis | Drug | ||
Variant | Cell Growth | Circulating | |||
MiRNA | EMT | Metastasis | |||
Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
Cancer Name | ovarian cancer |
ICD-0-3 | C56.9 |
Methods | qPCR, RNAi, Western blot, Cell migration and invasion assay etc. |
Sample | ovarian cancer tissues, cell lines (CoC1, CaoV-3, OVCAR3, and SKOV3) |
Expression Pattern | up-regulated |
Function Description | The transcriptional level of MIR4697HG was increased in cancerous tissues and ovarian cancer cell lines.MIR4697HG knockdown by specific shRNA significantly inhibited cell proliferation and colony formation in both OVCAR3 and SKOC3 cells. Furthermore, MIR4697HG knockdown inhibited cell migration and invasion capacities. MIR4697HG knockdown also caused a decrease in matrix metalloprotease-9, phosphorylated ERK, and phosphorylated AKT. |
Pubmed ID | 28168162 |
Year | 2017 |
Title | Long Noncoding RNA MIR4697HG Promotes Cell Growth and Metastasis in Human Ovarian Cancer. |
External Links
Links for MIR4697HG | GenBank HGNC NONCODE |
Links for ovarian cancer | OMIM COSMIC |